Search for Clinical Trial Results

Sponsored By

Hepatitis D, Chronic - 20 Studies Found

Status Study
Active, not recruiting Study Name: A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.
Condition: Hepatitis D, Chronic
Date: 2010-03-16
Interventions:
  • Drug: peginterferon alfa-2a [Pegasys]

Active, not recruiting Study Name: Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D
Condition: Hepatitis D, Chronic
Date: 2017-03-26
Interventions:
  • Drug: Pegylated interferon alfa

Completed Study Name: A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, Chronic
Date: 2016-04-05
Interventions: Drug: Pegylated Interferon (PEG-IFN) alfa-2a Participants received pegylated interferon (PEG-IFN) alfa-2
Completed Study Name: A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, Chronic
Date: 2016-04-01
Interventions:
  • Drug: Peginterferon alfa-2a Pe
Terminated Study Name: An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)
Condition: Hepatitis D, Chronic
Date: 2013-05-02
Recruiting Study Name: Ezetimibe for Patients With Chronic Hepatitis D
Condition: Chronic Hepatitis D
Date: 2017-03-28
Interventions: Drug: Ezetimibe Ezetimibe 20 mg oral daily
Recruiting Study Name: A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection
Condition: Hepatitis D, Chronic
Date: 2016-05-05
Interventions: Drug: Lambda
Not yet recruiting Study Name: A Study of Lonafarnib With or Without Ritonavir in Patients With HDV
Condition: Chronic Delta Hepatitis
Date: 2016-11-15
Interventions:
  • Drug: Lonafarnib antiviral far
Completed Study Name: Titrating-Dose of Lonafarnib in Combination With Ritonavir
Condition: Chronic Delta Hepatitis
Date: 2015-08-13
Interventions:
  • Drug: lonafarnib antiviral far
Active, not recruiting Study Name: A Long Term Follow-up Study of Patients From the REP 301 Protocol
Condition:
  • Hepatitis B, Chronic
  • Hepatitis D, Chronic

Date: 2016-08-16
Next >>>